Opinion 12 Dec 2022 Artificial intelligence: a new era in rare genetic disease diagnosis …data you feed it. Limitations arise in the form of non-coding pathogenic variants, ancestry-specific bias in genomic datasets and patient data protection issues. Non-coding variants are regions of the DNA sequence… December 12, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2022 Mission Bio launches new cancer assay …sensitivity and specificity of commercial MRD tests used today both in research and to predict cancer recurrence in patients, leveraging the Tapestri Platform’s ability to measure DNA and surface protein… July 28, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2017 German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases …as Shire, and recently entered a collaboration with US-based FDNA to support FDNA’s comprehensive database that combines phenotypic and genomic information associated with over 8,000 rare diseases and genetic disorders…. June 13, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …precise DNA modifications without introducing double-strand breaks. This approach aims to offer a safer and more efficient alternative to traditional gene-editing tools like CRISPR-Cas9. In April 2025, Brink secured $4… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2019 Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test …renal cell carcinoma that we know of,” Karl Bergman, CEO of Elypta, told me. While most blood and urine cancer tests detect genetic material such as DNA, Elypta measures the… February 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Nov 2022 Beyond Biotech podcast 22: PacBio, Sierra Space …recently announced beta testing of its Onso Sequencing System. The benchtop short-read DNA sequencing platform is expected to provide a new level of accuracy by utilizing PacBio’s sequencing by binding… November 11, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 17 Aug 2022 The challenges of developing radiopharmaceuticals for cancer …are generating investor excitement, including immuno-oncology, DNA damage repair and protein degradation. Another emerging area with huge potential is the treatment of cancer using drugs that carry radioactive molecules, known… August 17, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2019 British AI Firm Gets €9M Boost to Develop Drug-Discovery Tech …CEO. EVA is an engine that has the ability to map the links between DNA sequence and the function of the corresponding proteins. It collects large amounts of data generated… October 24, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jan 2018 European Court Supports the Softening of CRISPR Gene Editing Rules …genes or pieces of DNA from other species was against EU law. However, the directive allowed mutagenesis techniques like irradiation, and confusion grew. Many breeders felt that gene editing should… January 22, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 31 Oct 2025 Spooky science: lab-grown breakthroughs or nightmares? …new organism, in this case, dodos and dire wolves. To ‘resurrect’ dire wolves, they retrieved DNA from a 13,000-year-old tooth and 72,000-year-old skull. They also extracted progenitor cells from blood samples of gray wolves,… October 31, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2022 Collaboration to develop new glioblastoma combination therapy nets €1.06M …production by using DNA immunization is vital to the project. “We are excited to bring our extensive expertise in antibody engineering to the OpSIS project. Additionally, our platforms in molecular… September 20, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jun 2021 The Top European Biotech Investment Rounds in May Last month saw huge biotech investment rounds dedicated to Covid-19 vaccines in Europe, including IPOs by Valneva and Vaccitech. However, a €227M (£195M) private round by the DNA sequencing giant… June 10, 2021 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email